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he  inhibition  of  cocaine-induced  locomotor  activity  by  CART  55-102
s  lost  after  repeated  cocaine  administration
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 i  g  h  l  i  g  h  t  s
CART  peptide  inhibited  cocaine-mediated  locomotion  after  single  cocaine  injection.
The  inhibitory  effect  of  CART  peptide  was  lost  after chronic  cocaine  administration.
The  effect  of  CART  peptide  was  not  recovered  even  after  cocaine  withdrawal.
The  persistent  loss  of  CART  peptide  effect  suggests  its role  in  cocaine  addiction.
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a  b  s  t  r  a  c  t
CART  peptide  is known  for having  an  inhibitory  effect  on  cocaine-  and  dopamine-mediated  actions  after
acute  administration  of  cocaine  and  dopamine.  In  this  regard,  it is  postulated  to  be  a homeostatic,  regu-
latory  factor  on  dopaminergic  activity  in the  nucleus  accumbens  (NAc).  However,  there  is  no data  on  the
effect  of CART  peptide  after  chronic  administration  of  cocaine,  and this  study  addresses  this.  It  was  foundeywords:
ART peptide
ART 55-102
ocaine
cute
hronic
that  CART  peptide  blunted  cocaine-induced  locomotion  (LMA)  after  acute administration  of  cocaine,  as
expected,  but it did  not  affect cocaine-mediated  LMA  after  chronic  administration  of  cocaine.  The  loss
of  CART  peptide’s  inhibitory  effect  did  not  return  for up to 9  weeks  after  stopping  the  repeated  cocaine
administration.  It  may  not  be surprising  that  homeostatic  regulatory  mechanisms  in  the  NAc are  lost  after
repeated  cocaine  administration,  and  that  this  may  be a  mechanism  in  the development  of  addiction.
© 2013 The Authors. Published by Elsevier Ireland Ltd. Open access under CC BY-NC-ND license.. Introduction
The nucleus accumbens (NAc) is part of the reward pathway of
he brain and is a major mediator of cocaine-induced behavioral
ffects including cocaine self-administration and cocaine-induced
ocomotor activity (LMA). Cocaine-induced behaviors are sensitive
o changes in the concentration of cocaine-and-amphetamine reg-
lated transcript (CART) peptide in the NAc [12–14]. An injection
f CART 55-102 into the NAc blunts the effects of acute adminis-
ration of cocaine and dopamine (DA) [13]. Conversely, depletion
f endogenous CART peptide in the NAc results in a potentiation
f cocaine-induced LMA  [14]. There is an enhanced expression of
ART in the NAc of human cocaine abusers [1,3]. Cocaine enhances
ART expression in the NAc of animals [5,7,9,11]. Because of these
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Open access under CC BYﬁndings, it has been postulated that CART peptide is a homeo-
static regulator of DA- and cocaine-induced actions in the NAc
[13,23].
Repeated administration of cocaine can induce persistent alter-
ations in the structure and function of the NAc (a) shortly after
the last cocaine administration and (b) several weeks after with-
drawal from repeated cocaine administration [2,6,8,16–18,24,28].
For instance, chronic intermittent administration of cocaine led to
a lowering of basal DA levels in the NAc [22]. Also, repeated daily
injections of cocaine (10 mg/kg, i.p.) for 15 days resulted in a signif-
icant increase in the number of DA D2 receptor (D2R) binding sites
[8,17] and a decrease [17] in the number of DA D1 receptor (D1R)
binding sites in the NAc shortly after cessation of cocaine admin-
istration, but these changes were absent 2 weeks after halting
the cocaine administration. Furthermore, chronic cocaine exposure
increased the density of dendritic spines in the NAc shell shortly
after chronic cocaine administration but there was  a return to base-
line 4 weeks after cocaine withdrawal. In the NAc core on the other
hand, spines were unchanged shortly after repeated cocaine admin-
istration but were persistently decreased 4 weeks after withdrawal
[6]. These ﬁndings suggest that there are dynamic changes in the
-NC-ND license.
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Ac after cocaine administration that presumably contribute to the
ddictive effect of cocaine.
Repeated intravenous administration of cocaine down regulates
A D3 receptors in the NAc [25] and DA D3 receptors D3R reg-
late CART mRNA in the NAc [4,10]. Furthermore, CART peptide
ttenuates the effect of combined, acute DA D1–D2 receptor acti-
ation [19], but repeated cocaine treatment causes a dysregulation
f DA D1–D2 dopamine receptor signaling [2]. With these struc-
ural and functional changes in the NAc (a) shortly after chronic
dministration of cocaine and (b) after withdrawal from repeated
dministration of cocaine, it is important to determine if there are
orresponding changes in the effect of CART peptide on cocaine-
ediated effects. In this study, we looked at the effect of CART
eptide on LMA  after acute and chronic administration of cocaine
nd after withdrawal from chronic cocaine treatments.
. Materials and methods
A  total of 41 male Sprague Dawley rats (Charles River Inc.,
ilmington, MA), weighing 386–542 g during locomotor activity
LMA) experiments were used. They were provided rat chow and
ater ad libitum, and maintained on a 12 h light:dark cycle (lights
n at 7 am). Experiments and animal care were in accordance with
he Institute of Animal Care and Use Committee of Emory Uni-
ersity and the National Institutes of Health Guide for the Care
nd Use of Laboratory Animals. The rats were implanted, under
soﬂurane anesthesia, with bilateral stainless steel guide cannulae
ssembly (22 gauge; Plastics One; Roanoke, VA) using the follow-
ng coordinates for the shell-core border of the nucleus accumbens:
/P 1.6 mm,  L/M ± 1.5 mm,  D/V −5.7 mm [21]. The experiments
ere designed to determine the effect of CART 55-102 on cocaine-
ediated LMA – (a) after single cocaine injection, (b) after chronic
ocaine injection, (c) 3 weeks after chronic cocaine and (d) 9 weeks
fter chronic cocaine.
On  experiment day, rats were placed into locomotor chambers
or 30 min  to habituate to their surroundings before the recording
f basal LMA commenced. After 30 min  of basal LMA  recording, rats
ere removed from the chambers, infused with saline (0.5 L/side)
r CART 55-102 (2.5 g in 0.5 L of saline/side) immediately before
n i.p. injection of an equivalent volume of saline (1 mL/kg) or
ocaine (10 mg/kg), and placed back into the chambers for 60 min
f additional LMA recording. The selected dose of CART peptide
2.5 g) and the selected dose of cocaine (10 mg/kg i.p.) were used
ecause of their effectiveness in previous studies [13]. The chronic
ocaine (or saline) regimen proceeded every day after the above
xperiment and involved administration of i.p. cocaine (10 mg/kg)
or saline) to rats once daily. On the 14th day, like the 1st day,
ocaine-mediated LMA  was measured. The rats that received saline
nfusion into the NAc before chronic cocaine (or chronic saline)
eceived CART 55-102 after chronic cocaine (or chronic saline),
nd vice versa in a counterbalanced design. There were no sig-
iﬁcant differences in the body weights between the acute and
hronic administration groups. For some animals, the experiment
ontinued for up to 9 weeks after cessation of chronic cocaine
dministration. For these animals, each rat received both saline and
ART 55-102 infusions into the NAc plus i.p. cocaine in two exper-
mental days separated by at least 72 h apart (counterbalanced
esign) and LMA was measured.
On experiment days, intra-accumbal infusions were done
sing stainless steel bilateral injector cannulae (28 gauge, Plas-
ics One), connected via polyethylene-50 (PE-50) tubing to two
5 L microsyringes (Hamilton Co, Reno, NV). The two microsy-
inges were driven by pumps connected to Micro4 Microsyringe
ump Controller (World Precision Instruments, Sarasota, FL). Fluid
as bilaterally injected (0.5 L/side) for 30 s. The injected ﬂuidtters 550 (2013) 179– 183
was  allowed to diffuse for an additional 30 s before removal of
the injector cannluae. LMA  was measured in 10 min intervals
using a photocell cage (Omnitech Electronics, Columbus, OH)  with
transparent plexiglass walls (40 cm × 40 cm × 30 cm), containing
32 photobeams located 5 cm above the ﬂoor to record LMA. Each
cage was placed in a stainless steel box and connected to a com-
puter equipped with software (Digipro; Omnitech Electronics) to
measure LMA.
After  completion of the experiments, animals received an over-
dose of Ketamine (70 mg/kg) and dexmedetomidine (0.5 mg/kg),
and were then perfused intracardially with saline and 4%
paraformaldehyde in saline. After removal from the skull, brains
were placed in 4% paraformaldehyde overnight, followed by
immersion in 30% sucrose for several days and sliced (60 m slices)
using a cryostat (Leica CM1900, Leica CM3050S, Leica Microsys-
tems, Germany). Nissl staining was  performed to further conﬁrm
placement of the injector tips. A stereotaxic brain atlas was used to
approximate the placement of the injector tips.
Data are all expressed as mean ± SEM, and signiﬁcance occurs
when p < 0.05. All analyses were performed using GraphPad Prism
version 5.00 for Windows (GraphPad Software, San Diego California
USA, www.graphpad.com). LMA  data were acquired in 10-min bins
and time course data and total locomotor activity data were ana-
lyzed. For analysis of the time course data, a 2-way Repeated
Measures ANOVA with Bonferroni post-test was used to check if
there were main effects of treatment groups (between subjects),
time (within subjects) and a treatment groups × time interaction.
For time course data, the factors were treatment groups (4 levels:
saline + saline, CART + saline, saline + cocaine, CART + cocaine) and
time (9 levels). LMA  data were also analyzed as total locomotor
activity in 60 min  – a summation of individual locomotor activity
values for 60 min  post-injection. For analysis of the total locomotor
activity data, a 2-way ANOVA with Bonferroni post-test was  used.
For the total LMA  data, the factors were treatment groups (4 levels)
and chronic cocaine (2 levels: before and after). For analysis com-
paring LMA  data before and after chronic cocaine administration, a
2-way ANOVA with Bonferroni post-test was  used. Here, the factors
were treatment groups (2 levels: saline + cocaine, CART + cocaine)
and chronic cocaine (4 levels: before, at, 3 weeks after, at 9 weeks
after).
3. Results
Rats received injections into the NAc of either saline alone or
CART 55-102 alone, which was then immediately followed with
an i.p. injection of either saline or cocaine, and LMA  was mea-
sured. Measurements were made after one or 14 daily injections
of cocaine (10 mg/kg) or saline. When the individual time points
of LMA  were analyzed separately (Fig. 1) or combined (total LMA)
(Fig. 2), signiﬁcant differences were found. Cocaine increased total
LMA  as expected, and CART 55-102 reduced cocaine-induced LMA
as expected (Figs. 1 and 2) after a single injection of cocaine (on day
1). However, on day 14, after the repeated daily cocaine admin-
istration regimen, cocaine increased LMA  as expected, but CART
55-102 had no effect on cocaine-induced LMA  (Figs. 1 and 2). Fur-
thermore, CART 55-102 did not reduce cocaine-induced LMA at 3
or 9 weeks after withdrawal from the chronic cocaine administra-
tion (Fig. 3). Thus, the loss of the inhibitory effect of CART 55-102
was long-lasting. The locations of the injections into the NAc were
determined as described in Methods and as expected they were
found throughout the extent of the NAc (Fig. 4).4. Discussion
CART peptide attenuated cocaine-induced LMA  after acute
administration of cocaine, but this effect was  lost after repeated
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Fig. 1. Time course of cocaine-induced locomotor activity. CART 55-102 (2.5 g)
or saline was administered directly into the NAc of male rats immediately before
a  single i.p. injection of saline or cocaine (coc) (10 mg/kg) (day 1) and after addi-
tional 13 days (day 14) of cocaine (10 mg/kg) administration once daily, and LMA
was measured. The groups were as follows–single coc administration [saline + saline
(n = 6), CART + saline (n = 5), saline + coc (n = 15), CART + coc (n = 15)] and chronic
coc  administration [saline + saline (n = 5), CART + saline (n = 6), saline + coc (n = 13),
CART + coc (n = 13)]. The rats that received CART on day 1 received saline on
day 14, and vice versa. The y-axis represents total distance covered. Top graph –
2-way repeated measures ANOVA of time course data (after single cocaine injec-
tion) showed a signiﬁcant treatment group effect (F3, 37 = 18.08, ***p < 0.0001), a
signiﬁcant time effect (F8, 296 = 23.07, ***p < 0.0001) and a signiﬁcant interaction
(F24, 296 = 6.244, ***p < 0.0001). Bonferroni post hoc tests showed that saline + saline
was  not different from CART + saline at all time points. Saline + saline was  different
from  saline + coc at all time points. Saline + saline was  different (*) from CART + coc
only at the 3rd time (30 min) point after injection. Saline + coc was different (#)
from CART + coc at the 2nd to 5th time points (50–80 min) after injection. 1-way
ANOVA of the individual treatment groups was  done to determine the effect of
injection by comparing the time point just before injection (time = 30 min) and all
the time points post-injection. Bottom graph – 2-way repeated measures ANOVA
of  time course data (after chronic cocaine regimen) showed a signiﬁcant treat-
ment  group effect (F3, 33 = 5.200, **p = 0.0047), a signiﬁcant time effect (F8, 264 = 16.24,
***p  < 0.0001) and a signiﬁcant interaction (F24, 264 = 6.306, ***p < 0.0001). Bonfer-
roni  post hoc tests showed that saline + saline was not different from CART-saline
at  all time points. Saline + saline was different from saline + coc up to 4 time points
after  cocaine injection. Saline + saline was  different (*) from CART + coc from the
2nd–5th time (50–80 min) point after injection. Saline + coc was not different from
CART + coc at any time point after injection. 1-way ANOVA of the individual treat-
ment groups was  done to determine the effect of injection by comparing the time
point just before injection (time = 30 min) and all the time points post-injection.
The  p-values *p < 0.05, **p < 0.01, ***p < 0.001 show difference when comparing all
groups to saline-saline. The p-values #p < 0.05, ##p < 0.01, ###p < 0.001 show differ-
ence  when comparing between saline + coc and CART + coc groups. The p-values
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Fig. 2. The effect of CART peptide after both single and repeated injections of
cocaine.  The data is a summation of the time points after cocaine (coc) adminis-
tration  in Fig. 1. The rats that received CART on day 1 received saline on day 14, and
vice versa. The y-axis represents total distance covered in 60 min  after cocaine (or
saline) injection. 2-way ANOVA showed a signiﬁcant treatment effect (F3,  70 = 12.58,
***p < 0.0001), an almost signiﬁcant chronic coc effect (F1, 70 = 2.974, p = 0.0890) and
an interaction (F3, 70 = 3.052, *p = 0.0341). Bonferroni post hoc tests showed that
CART  + coc was signiﬁcantly different from saline + coc on day 1 but was not dif-
ferent  after chronic cocaine administration. Bonferroni post hoc tests also showed
that the effect of CART + coc was signiﬁcantly different after chronic coc administra-
tion.  The p-values *p < 0.05, **p < 0.01, ***p < 0.001 show difference when comparing
all  groups to saline + saline. The p-values #p < 0.05, ##p < 0.01, ###p < 0.001 show dif-
ference  when comparing between saline + coc and CART + coc groups. The p-values
+p < 0.05, ++p < 0.01, +++p < 0.001 show the difference when comparing treatments
between  day 1 (before chronic cocaine) and day 14 (after chronic cocaine). The
signiﬁcant differences after post hoc analysis are shown in the graph.
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Fig. 3. The effect of CART peptide after withdrawal of repeated injections of cocaine.
CART 55-102 (2.5 g) or saline was administered directly into the NAc of male rats
immediately before an i.p. injection of saline or cocaine (coc) (10 mg/kg) acutely
(day  1), after additional 13 days (day 14) of cocaine (10 mg/kg) administration
once  daily and at different time points after withdrawal of chronic administration
of  cocaine-10 mg/kg and LMA  was  measured. The groups were as follows (before
chronic  coc administration) [saline + coc (n = 15), CART + coc (n = 15)], (after chronic
coc administration) [saline + coc (n = 13), CART + coc (n = 13)] (3 weeks after chronic
coc administration) [saline + coc (n = 10), CART + coc (n = 10)], and (9 weeks after
chronic  coc administration) [saline + coc (n = 7), CART + coc (n = 8)]. The y-axis rep-
resents distance covered in 60 min  after cocaine injection. The x-axis represents the
conditions relative to chronic coc administration. 2-way ANOVA showed no signif-
icant treatment effect (F1, 83 = 0.03841, p = 0.8451), a signiﬁcant difference between
conditions  relative to time before chronic coc (F3, 83 = 5.199, **p = 0.0024) and no
interaction (F3, 83 = 1.931, p = 0.1309). Bonferroni post hoc tests showed that the effect
of CART + coc before chronic coc was  signiﬁcantly different from its effect after
chronic  coc and even after allowing rat to recover for up to 9 weeks after chronicp < 0.05, p < 0.01, p < 0.001 show difference when comparing pre-injection time
oint (time = 30 min) to all post-injection time points for each group. The signiﬁcant
ifferences  after post hoc analysis are shown in the graph.
14 days) cocaine administration. Also, the CART peptide inhibitory
ffect on cocaine-induced LMA  did not return even after 9 weeks
f withdrawal from repeated cocaine administration. Our study
onﬁrms the effect of intra-NAc CART peptide on acute cocaine
dministration [13], and shows for the ﬁrst time that the inhibitory
ffect of CART peptide is lost after repeated, non-contingent cocaine
coc.  The p-values *p < 0.05, **p < 0.01, ***p < 0.001 show difference when compar-
ing  treatment groups between all conditions relative to chronic coc. The signiﬁcant
differences  after post hoc analysis are shown in the graph.
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[15] G.L. Keating, M.J. Kuhar, D.B. Rye, High dose CART peptide induces abnormalig. 4. The histological analysis of the rat brains showing injection regions in the
Ac. The numbers are coordinates from Bregma in millimeters [21].
dministration. Our results are supported by a study showing that
 weeks after withdrawal from chronic cocaine regimen (15 mg/kg
.p. x 7 days), intra-NAc infusion of CART 55-102 (2.5 g) inhibited
ocomotor sensitization but not locomotor activity per se after
ocaine (10 mg/kg i.p.) administration [26]. Our data implies that
hronic cocaine persistently altered the CART peptide system in
he NAc. Other systems in the NAc that are similarly dysregulated
y chronic cocaine include the Orexin [27] and Dynorphin A [20]
ystems, with alterations persisting even beyond 2 months after
essation of repeated cocaine [27].
Cocaine-induced LMA  is due to DA effect in the NAc and CART
eptide attenuates acute DA-mediated LMA  by suppressing the
ffect of a combined activation of D1R and D2R [13,19]. After
hronic cocaine administration in a similar experimental design
cocaine 10 mg/kg i.p. × 15 days), D1R were transiently reduced in
he NAc while D2R were increased in the NAc [17]. Given that CART
[tters 550 (2013) 179– 183
peptide  attenuates the LMA  of a combined D1R and D2R activation,
the change in D1R to D2R ratio or effect in the NAc shortly after
chronic administration of cocaine may  be at least part of the mecha-
nism of the effects of CART peptide (or lack of) in our study. Another
possible mechanism of our results is that CART peptide is still effec-
tive but requires much higher doses to produce an effect. This could
not be tested because higher doses of CART 55-102 tend to produce
convulsions [15]. In any case, this would still be a cocaine-induced
dysfunction of the CART peptide system in the NAc.
In  conclusion, CART peptide attenuated cocaine-induced LMA
after acute administration of cocaine as expected, but the inhibitory
effect was lost after repeated cocaine administration and the CART
peptide effect did not return even after 9 weeks of withdrawal
from repeated cocaine administration. It is important to note that
the studies herein are limited to LMA, and that studies with self-
administration or conditioned place preference are needed as well
to fully conclude that such a loss of an inhibitory system after
repeated cocaine administration may be a mechanism underlying
the state of addiction.
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